Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Immunological Methods|May 15, 2025
Comparison of mixed modeling regression methods for the assessment of longitudinal CyTOF® dataTyson H Holmes, Caroline DuaultBiochemical Society Transactions|April 15, 2017
CD81 as a tumor targetFelipe Vences-Catalán, Caroline Duault, Chiung-Chi Kuo, et al.Immunology Letters|June 14, 2014
Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytesEmilie Decaup, Caroline Duault, Christine Bezombes, et al.European Journal of Immunology|July 26, 2017
IL-33-expanded human Vγ9Vδ2 T cells have anti-lymphoma effect in a mouse tumor modelCaroline Duault, Delphine Betous, Christine Bezombes, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 27, 2015
TCRVγ9 γδ T Cell Response to IL-33: A CD4 T Cell-Dependent MechanismCaroline Duault, Don Marc Franchini, Julien Familliades, et al.The Journal of Experimental Medicine|May 25, 2019
CD81 is a novel immunotherapeutic target for B cell lymphomaFelipe Vences-Catalán, Chiung-Chi Kuo, Ranjani Rajapaksa, et al.Blood|June 2, 2021
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemiaCaroline Duault, Anil Kumar, Adeleh Taghi Khani, et al.Journal for Immunotherapy of Cancer|August 28, 2021
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)Russell K Pachynski, Chihiro Morishima, Russell Szmulewitz, et al.Journal for Immunotherapy of Cancer|May 22, 2023
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemiaAnil Kumar, Adeleh Taghi Khani, Caroline Duault, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2021
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDCBita Sahaf, Mina Pichavant, Brian H Lee, et al.Pageof 2